KERACNYL PP+ cream
Anti-blemish cream alone, in combination or as a relay to treatments
KERACNYL PP+ cream
Anti-blemish cream alone, in combination or as a relay to treatments
Status
Status :
Completed
Type of study
Post-marketing study
Min. Age
12
Years old
Max. Age
61
Years old
Gender
All
Brief summary
The objectives of this study were to evaluate the efficacy and tolerance of KERACNYL PP+ cream on acne-prone skin. The cream was used alone, in combination or as a relay to treatments.
The subjects' skin was evaluated during 2 dermatological consultations spaced 3 months apart.
Area of application :
Dermatology
Target :
Acne-prone skin
Dermo-cosmetic product :
KERACNYL PP+ anti-blemish cream
Brand :
Ducray
Start Date :
01 September 2022
End Date :
30 January 2022
Number of subjects :
1133
Countries :
Colombia
Dominican Rep.
France
Germany
Greece
Italy
Morocco
Poland
Spain
Tunisia
Study ID :
DU-RV4133C-2022-01